NASDAQ: ARWR
Arrowhead Pharmaceuticals Inc Earnings Dates, Reports, Calls

Arrowhead Pharmaceuticals earnings were -$320.0M for the trailing 12 months ending Jun 30, 2026, with N/A growth year over year. The latest ARWR earnings report on Jun 30, 2026 announced Q2 2026 earnings of -$194.3M, up 46.4% from last quarter. For the last reported fiscal year 2025 ending Sep 30, 2025, ARWR reported annual earnings of -$1.6M, with -99.7% growth. The next ARWR earnings date is Nov 24, 2026.

ARWR earnings history

Current Revenue
$669.5M
Current Earnings
-$320.0M
Current Profit Margin
-47.8%

ARWR Return on Equity

Current Company
-60.5%
Current Industry
-10.8%
Current Market
30.9%
ARWR's Return on Equity (-60.5%)... subscribe to Premium to read more.
High Return on Equity Performance

ARWR Return on Assets

Current Company
-17.4%
Current Industry
-10.7%
ARWR is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when ARWR announces earnings.

ARWR Return on Capital Employed

Current Company
-11.34%
Current Industry
-7.4%
ARWR has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

ARWR vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
ARWR-$181.49M-$319.95MN/A-$2.25
CYTK-$826.65M-$894.00MN/A-$7.22
SYRE-$178.92M-$178.92MN/A-$1.99
IBRX-$854.88M-$992.36MN/A-$0.97
CORT$7.85M$54.20M-8.80%$0.53

ARWR earnings dates

Next earnings date
Nov 24, 2026

Arrowhead Pharmaceuticals Earnings Reports & History FAQ

What were Arrowhead Pharmaceuticals's earnings last quarter?

On ARWR's earnings call on Aug 4, 2026, Arrowhead Pharmaceuticals (NASDAQ: ARWR) reported Q2 2026 earnings per share (EPS) of -$1.36, up 7.94% year over year. Total ARWR earnings for the quarter were -$194.28 million. In the same quarter last year, Arrowhead Pharmaceuticals's earnings per share (EPS) was -$1.26.

If you're new to stock investing, here's how to buy Arrowhead Pharmaceuticals stock.

When does Arrowhead Pharmaceuticals report earnings?

The next ARWR earnings call is Nov 24, 2026. Add ARWR to your watchlist to be reminded of Arrowhead Pharmaceuticals's next earnings date.

Is Arrowhead Pharmaceuticals profitable or losing money?

As of the last Arrowhead Pharmaceuticals earnings report, Arrowhead Pharmaceuticals is currently losing money. Arrowhead Pharmaceuticals's net profit (also called net income) for the twelve months ending Jun 30, 2026 was -$319.95 million, a 115.58% increase year over year.

What was ARWR's earnings growth in the past year?

As of Arrowhead Pharmaceuticals's earnings date in Aug 4, 2026, Arrowhead Pharmaceuticals's earnings has grown year over year. ARWR earnings in the past year totalled -$319.95 million.

What are Arrowhead Pharmaceuticals's earnings expectations?

The current EPS estimate for Arrowhead Pharmaceuticals's earnings report in Nov 24, 2026 is -$1.59.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.